These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20347897)

  • 1. Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles.
    Agüeros M; Zabaleta V; Espuelas S; Campanero MA; Irache JM
    J Control Release; 2010 Jul; 145(1):2-8. PubMed ID: 20347897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined hydroxypropyl-beta-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel.
    Agüeros M; Ruiz-Gatón L; Vauthier C; Bouchemal K; Espuelas S; Ponchel G; Irache JM
    Eur J Pharm Sci; 2009 Nov; 38(4):405-13. PubMed ID: 19765652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study.
    Zabaleta V; Ponchel G; Salman H; Agüeros M; Vauthier C; Irache JM
    Eur J Pharm Biopharm; 2012 Aug; 81(3):514-23. PubMed ID: 22516136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclodextrin-poly(anhydride) nanoparticles as new vehicles for oral drug delivery.
    Agüeros M; Espuelas S; Esparza I; Calleja P; Peñuelas I; Ponchel G; Irache JM
    Expert Opin Drug Deliv; 2011 Jun; 8(6):721-34. PubMed ID: 21463219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled Release, Intestinal Transport, and Oral Bioavailablity of Paclitaxel Can be Considerably Increased Using Suitably Tailored Pegylated Poly(Anhydride) Nanoparticles.
    Calleja P; Espuelas S; Vauthier C; Ponchel G; Irache JM
    J Pharm Sci; 2015 Sep; 104(9):2877-86. PubMed ID: 25600579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded nanosponges.
    Torne SJ; Ansari KA; Vavia PR; Trotta F; Cavalli R
    Drug Deliv; 2010 Aug; 17(6):419-25. PubMed ID: 20429848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral delivery of camptothecin using cyclodextrin/poly(anhydride) nanoparticles.
    Huarte J; Espuelas S; Lai Y; He B; Tang J; Irache JM
    Int J Pharm; 2016 Jun; 506(1-2):116-28. PubMed ID: 27102993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid lipid nanoparticles of paclitaxel strengthened by hydroxypropyl-β-cyclodextrin as an oral delivery system.
    Baek JS; So JW; Shin SC; Cho CW
    Int J Mol Med; 2012 Oct; 30(4):953-9. PubMed ID: 22859311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation.
    Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X
    Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclodextrin/poly(anhydride) nanoparticles as drug carriers for the oral delivery of atovaquone.
    Calvo J; Lavandera JL; Agüeros M; Irache JM
    Biomed Microdevices; 2011 Dec; 13(6):1015-25. PubMed ID: 21773725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioadhesive properties and biodistribution of cyclodextrin-poly(anhydride) nanoparticles.
    Agüeros M; Areses P; Campanero MA; Salman H; Quincoces G; Peñuelas I; Irache JM
    Eur J Pharm Sci; 2009 Jun; 37(3-4):231-40. PubMed ID: 19491010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
    Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X
    Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient oral delivery of paclitaxel using cyclodextrin complexes.
    Park K
    J Control Release; 2010 Jul; 145(1):1. PubMed ID: 20472008
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles.
    Letchford K; Liggins R; Wasan KM; Burt H
    Eur J Pharm Biopharm; 2009 Feb; 71(2):196-206. PubMed ID: 18762253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery.
    Bilensoy E; Gürkaynak O; Doğan AL; Hincal AA
    Int J Pharm; 2008 Jan; 347(1-2):163-70. PubMed ID: 17689901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability.
    Zeng N; Hu Q; Liu Z; Gao X; Hu R; Song Q; Gu G; Xia H; Yao L; Pang Z; Jiang X; Chen J; Fang L
    Int J Pharm; 2012 Mar; 424(1-2):58-66. PubMed ID: 22240390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo.
    Zhu Z; Li Y; Li X; Li R; Jia Z; Liu B; Guo W; Wu W; Jiang X
    J Control Release; 2010 Mar; 142(3):438-46. PubMed ID: 19896997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs.
    Zhao Z; He M; Yin L; Bao J; Shi L; Wang B; Tang C; Yin C
    Biomacromolecules; 2009 Mar; 10(3):565-72. PubMed ID: 19175304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells.
    Baek JS; Cho CW
    J Pharm Pharmacol; 2013 Jan; 65(1):72-8. PubMed ID: 23215690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.